Spermine

Spermine

SCHEMBL288605

NCCCCN.NCCCNCCCCNCCCN

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 1.00
CA6 P23280 5/20 1.00
CA7 P43166 5/20 1.00
CA9 Q16790 5/20 1.00
CA14 Q9ULX7 5/20 1.00
CA5B Q9Y2D0 5/20 1.00
CA2 P00918 4/20 1.00
CA4 P22748 4/20 1.00
CA5A P35218 4/20 1.00
ALOX15 P16050 3/20 1.00
CA3 P07451 3/20 1.00
F13A1 P00488 2/20 1.00
CYP1A2 P05177 2/20 1.00
THPO P40225 2/20 1.00
CA1 P00915 2/20 1.00
CYP2C9 P11712 1/20 1.00
PKM P14618 1/20 1.00
TSHR P16473 1/20 1.00
MTOR P42345 1/20 1.00
LMNA P02545 3/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165201 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermidine SCHEMBL8073115 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermidine SCHEMBL288987 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL3175232 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermine SCHEMBL431884 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermine SCHEMBL5802297 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermidine SCHEMBL15618 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
Spermidine SCHEMBL6253721 1.00 CA12 (1.00) CA12CA6CA7CA9CA14
SCHEMBL4861043 0.97 CA12 (0.93) CA12CA6CA7CA9CA14
Spermidine SCHEMBL573651 0.97 LMNA (1.00) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635905-A2 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE AbbVie Inc. (US) 2013-09-11 EP claimed
WO-2012078270-A2 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE ABBOTT LABORATORIES (ES) 2012-06-14 WO claimed
US-20120129727-A1 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE ABBOTT LABORATORIES (US) 2012-05-24 US claimed
US-9068970-B2 Efficient and effective supplement screening for the development of chemically defined media in cell culture ABBVIE INC. (US) 2015-06-30 US disclosed
EP-2635905-A2 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE AbbVie Inc. (US) 2013-09-11 EP disclosed
WO-2012078270-A2 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE ABBOTT LABORATORIES (ES) 2012-06-14 WO disclosed
US-20120129727-A1 EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE ABBOTT LABORATORIES (US) 2012-05-24 US disclosed
EP-2427773-A1 METHOD OF DIAGNOSING ASPHYXIA Keller, Matthias (DE) 2012-03-14 EP disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 WO disclosed
WO-1998013037-A1 METHODS OF USING AGMATINE TO REDUCE INTRACELLULAR POLYAMINE LEVELS AND TO INHIBIT INDUCIBLE NITRIC OXIDE SYNTHASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-04-02 WO disclosed